Brain Wave Analyzer Market Report 2024

The brain wave analyzer market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the increasing prevalence of neurological disorders, heightened awareness about mental health, rising research and development activities, increased healthcare expenditure, and growing interest in brain-computer interfaces.

The brain wave analyzer market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to the increasing adoption of neurofeedback therapy, the rising incidence of neurological disorders, the expansion of telehealth services, the growing applications in sleep disorder diagnosis, and the expansion in the sports and fitness industry. Major trends during this period include advancements in brain-computer interfaces, the integration of AI and machine learning, the development of portable and wearable devices, the implementation of non-invasive techniques, and the expansion into non-medical applications.

The rising prevalence of neurological disorders is anticipated to drive the growth of the brain wave analyzer market. Neurological disorders encompass conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. The increase in these disorders is attributed to factors such as heightened stress, poor diet, lack of exercise, and exposure to environmental toxins. Brain wave analyzers, utilizing electroencephalograph (EEG) technology, assist in diagnosing and managing neurological disorders by measuring brain activity to identify abnormalities, monitor disease progression, inform treatment plans, and support therapeutic interventions. For example, according to the Alzheimer's Association, a US-based non-profit voluntary health organization, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, a neurological disorder, in March 2023. This number is projected to rise to 13.8 million by 2060. Thus, the increasing prevalence of neurological disorders is driving the expansion of the brain wave analyzer market.

Leading companies in the brain wave analyzer market are focusing on strategic investments to introduce innovative devices with advanced features. These investments foster innovation, enhance technological integration, expand market reach, ensure regulatory compliance, and improve customer education and operational efficiency, thereby driving growth and competitiveness. For instance, in September 2021, Yokogawa Electric Corporation, a Japan-based electrical engineering and software company, invested in CyberneX Co. Ltd., a Japan-based company, to develop a compact earphone-type device for real-time brainwave measurement. This technology aims to revolutionize healthcare, education, and industry by capturing brainwave data easily, even during movement, and integrating physiological data for enhanced applications, positioning CyberneX and Yokogawa at the forefront of innovation in the brainwave analyzer market.

In July 2022, ArchiMed, a France-based investment firm, acquired Natus Medical Incorporated for an undisclosed amount. This acquisition aims to strategically enhance Natus Medical's international expansion, strengthen its market position in neuroscience, intensify research and development, and pursue synergistic acquisitions, ultimately advancing patient care and driving company growth. Natus Medical Incorporated, a US-based company, specializes in the production of diagnostic and monitoring equipment for neurological disorders, including brainwave analyzers and hearing screening devices.

Major companies operating in the brain wave analyzer market are Medtronic plc, Nihon Kohden Corporation, Natus Medical Incorporated, NeuroPace Inc., Cadwell Industries Inc., NeuroSky Inc., Compumedics Limited, Brain Products GmbH, EMOTIV Inc., ANT Neuro B.V., Electrical Geodesics Incorporated (EGI Inc.), Neuroelectrics Corporation, BrainScope Company Inc., G.Tec Medical Engineering GmbH, Advanced Brain Monitoring Inc., NeuroWave Systems Inc., Noraxon USA Inc., BrainMaster Technologies Inc., Mind Media B.V., Mitsar Co. Ltd., Neurobit Systems Ltd., NeuroStyle Pte. Ltd., Neurovigil Inc., Qneuro Inc., Cortech Solutions Inc.

North America was the largest region in the brain wave analyzer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain wave analyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the brain wave analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A brain wave analyzer is a device that measures and records brain activity using scalp sensors. It is used to diagnose neurological conditions, monitor brain activity during surgery, and support brain function research. The benefits include early disorder detection, enhanced understanding of brain function, and improved patient monitoring.

The primary types of products in the brain wave analyzer market are software and hardware. Software encompasses programs and applications designed to analyze, interpret, and visualize brain wave data collected from various devices. The various applications include neurofeedback, sleeping aids, and quantum medicine, with end users including hospitals, neurology centers, clinics, and ambulatory surgical centers (ASCs).

The brain wave analyzer market research report is one of a series of new reports that provides brain wave analyzer market statistics, including the brain wave analyzer industry global market size, regional shares, competitors with brain wave analyzer market share, detailed brain wave analyzer market segments, market trends, and opportunities, and any further data you may need to thrive in the brain wave analyzer industry. These brain wave analyzer market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The brain wave analyzer market consists of revenues earned by entities by providing services such as neurological diagnostics, cognitive assessment, research tools, therapeutic monitoring, biofeedback training, healthcare IT solutions, and professional education. The market value includes the value of related goods sold by the service provider or included within the service offering. The brain wave analyzer market also includes sales of the brainbit eeg headset, muse eeg headband, and mindwave mobile. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.